Spain’s Richest Man is Moving Into Healthcare
The global rich list is splattered with household names who have built their reputation not only through business acumen but through eye-catching purchases such as Steve Balmer’s record buyout of…
Reig Jofre (RJ) Group is a family owned Company founded in 1929 and has exhibited strong growth in recent years. RJ is now established as a leading European Development and Manufacturing Company in the Pharmaceutical /Biopharmaceutical markets. The headquarters are located in Barcelona (Spain) and the Group is structured around four main Divisions: Industrial, Biotech, Research/Development & Regulatory and Sales & Marketing.
The Industrial Division provides specialised manufacturing activities through 4 manufacturing sites : RJ Toledo (Spain) has two independent facilities for Penicillin (FDA approved) and Cephalosporin specialties: RJ Barcelona (Spain) specialises in freeze-dried products with a “Center of Excellence in Lyophilisation”, and employs a strong scientific approach based on Quality by Design (QbD) processes, and RJ BIOGLAN –(Malmo, Sweden) Manufacture and R & D for semi-solid/topical products.
The RJ Group manufactures for more than 190 clients/distributors in 55 countries globally
The global rich list is splattered with household names who have built their reputation not only through business acumen but through eye-catching purchases such as Steve Balmer’s record buyout of…
LEO Pharma’s Paolo Cionini discusses recent structural changes in the dermatology specialist’s Europe South operations, the importance of Spain to the regional group, and the nation’s digital capabilities. The…
Dr Sergi Trilla, CEO and founder of life sciences business development provider trifermed, introduces the company and explains its evolution to better serve the shifting paradigms of the healthcare and…
One of the unique aspects of the system is the fragmentation linked to the country’s 17 autonomous regions The Spanish healthcare system performance is ranked as 7th in the world…
Following Bayer’s acquisition of Monsanto, a US agriculture giant, the company is facing a new era in which its pharmaceutical arm is still a highly strategic part. Bernardo Kanahuati, Bayer’s…
Oriol Segarra, CEO of Uriach, describes the Spanish OTC company’s recent developments and transformation from a domestic organization to a truly European player. These are very interesting times for…
Francesc Posas, the newly appointed director of the Institute for Research in Biomedicine (IRB Barcelona), explains the evolving role of the institute as a bridge between basic research and concrete…
Madrid, Spain’s capital, is the city with the highest life expectancy in Europe at 85.2 years. Moreover, Spain as a whole is one of Europe’s best performers in terms of…
Enrique Ruiz Escudero, Minister of Health of the Community of Madrid, discusses his strategy to maintain Madrid’s spot as having Spain’s leading healthcare system, the creation of the bio-region –‘Biomad’,…
Ignacio Vega and Carlos Ibares Sanz of Spanish medtech Cardiva, explain the group’s origins as a distributor, the growing importance of manufacturing, and the company’s international ambitions. How has…
Ana Fernández of Théa Spain discusses the strategic importance of the Spanish affiliate – the group’s oldest, current trends in Spanish ophthalmology, and what differentiates Théa – as a family-run…
Spanish stakeholders have been trailblazing the concept of the “liquid hospital”, which envisions the virtual and physical expansion of healthcare provision beyond the parameters of the traditional centralized hospital structure.…
See our Cookie Privacy Policy Here